- Home
- BBBYW vs MREO Comparison
BBBYW vs MREO Comparison
Compare BBBYW & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.58
HOLD
Current Price
$0.31
Company Overview
Basic Information| Metric | BBBYW | MREO |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.2M | 50.3M |
| IPO Year | 2002 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BBBYW | MREO |
|---|---|---|
| Price | $0.58 | $0.31 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 189.3K | ★ 1.3M |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.64 | 16.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,044,616,000.00 | $500,000.00 |
| Revenue This Year | N/A | $5,184.20 |
| Revenue Next Year | N/A | $55.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.52 | $0.20 |
| 52 Week High | $1.20 | $2.37 |
Technical Indicators
Market Signals| Indicator | BBBYW | MREO |
|---|---|---|
| Relative Strength Index (RSI) | 47.93 | 58.33 |
| Support Level | N/A | $0.27 |
| Resistance Level | $0.80 | $0.35 |
| Average True Range (ATR) | 0.15 | 0.02 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 9.79 | 94.27 |
Price Performance
Historical Comparison BBBYW
MREO
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).